Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell
• Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
InspireMD Earnings Preview
InspireMD (NASDAQ:NSPR) is set to give its latest quarterly earnings report on Monday, 2023-11-06. Here’s what investors need…
InspireMD Presents 30-Day Follow-Up Results From The C-GUARDIANS U.S. Investigational Device Exemption Clinical Trial At VIVA23
InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today presented 30-day results from the C-GUARDIANS U.S. Investigational Device Exemption
InspireMD Announces Abstract Of 30-Day Results From The C-Guardians U.S. Investigational Device Exemption Clinical Trial Accepted for Presentation at VIVA23
InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that an abstract detailing upcoming 30-day results from its C-Guardians
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers Enhabit (NYSE:EHAB) stock increased by 8.2% to $12.92 during Wednesday’s after-market session. The company’s market cap stands…
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Virpax Pharmaceuticals (NASDAQ:VRPX) stock moved upwards by 9.6% to $1.0 during Friday’s after-market session. The market value…
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers Healthcare Triangle (NASDAQ:HCTI) stock rose 109.2% to $6.82 during Wednesday’s regular session. Healthcare Triangle’s stock is trading…
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Renalytix (NASDAQ:RNLX) shares moved upwards by 38.6% to $2.87 during Friday’s pre-market session. The company’s market cap…
InspireMD Announces Completion Of Enrollment In C-Guardians U.S. Investigational Device Exemption Clinical Trial
Trial designed to support potential U.S. marketing approval of the CGuard™ Prime EPS stent system
Study also included first-in-human cases treated with CGuard Prime CAS stent delivery platform
Company